NO975527L - Use of alendronate to prevent osteoporosis - Google Patents
Use of alendronate to prevent osteoporosisInfo
- Publication number
- NO975527L NO975527L NO975527A NO975527A NO975527L NO 975527 L NO975527 L NO 975527L NO 975527 A NO975527 A NO 975527A NO 975527 A NO975527 A NO 975527A NO 975527 L NO975527 L NO 975527L
- Authority
- NO
- Norway
- Prior art keywords
- alendronate
- prevent osteoporosis
- osteoporosis
- prevent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45819595A | 1995-06-02 | 1995-06-02 | |
PCT/US1996/007912 WO1996038156A1 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for the prevention of osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975527D0 NO975527D0 (en) | 1997-12-01 |
NO975527L true NO975527L (en) | 1997-12-01 |
Family
ID=23819759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975527A NO975527L (en) | 1995-06-02 | 1997-12-01 | Use of alendronate to prevent osteoporosis |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0828496A1 (en) |
JP (1) | JPH10506648A (en) |
KR (1) | KR19990022436A (en) |
CN (1) | CN1192685A (en) |
AU (1) | AU709196B2 (en) |
BG (1) | BG63103B1 (en) |
BR (1) | BR9609020A (en) |
CA (1) | CA2222318A1 (en) |
CZ (1) | CZ381197A3 (en) |
EA (1) | EA000677B1 (en) |
EE (1) | EE03306B1 (en) |
HU (1) | HUP9900659A3 (en) |
IL (1) | IL118422A0 (en) |
IS (1) | IS4617A (en) |
NO (1) | NO975527L (en) |
NZ (1) | NZ308935A (en) |
PL (1) | PL323669A1 (en) |
SK (1) | SK159597A3 (en) |
TR (1) | TR199701482T1 (en) |
WO (1) | WO1996038156A1 (en) |
ZA (1) | ZA964465B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
SE9901272D0 (en) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
KR100317935B1 (en) * | 1999-10-20 | 2001-12-22 | 유승필 | Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
EP1392325B1 (en) * | 2001-05-02 | 2006-06-21 | Novartis AG | Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
JP2010043119A (en) * | 2009-10-16 | 2010-02-25 | Gador Sa | Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof |
KR102472749B1 (en) * | 2022-01-18 | 2022-12-02 | 주식회사 위엔씨 | Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366965A (en) * | 1993-01-29 | 1994-11-22 | Boehringer Mannheim Gmbh | Regimen for treatment or prophylaxis of osteoporosis |
US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
-
1996
- 1996-05-27 IL IL11842296A patent/IL118422A0/en unknown
- 1996-05-29 CN CN96196075A patent/CN1192685A/en active Pending
- 1996-05-29 NZ NZ308935A patent/NZ308935A/en unknown
- 1996-05-29 CZ CZ973811A patent/CZ381197A3/en unknown
- 1996-05-29 SK SK1595-97A patent/SK159597A3/en unknown
- 1996-05-29 PL PL96323669A patent/PL323669A1/en unknown
- 1996-05-29 HU HU9900659A patent/HUP9900659A3/en unknown
- 1996-05-29 WO PCT/US1996/007912 patent/WO1996038156A1/en not_active Application Discontinuation
- 1996-05-29 EE EE9700308A patent/EE03306B1/en not_active IP Right Cessation
- 1996-05-29 TR TR97/01482T patent/TR199701482T1/en unknown
- 1996-05-29 EA EA199700449A patent/EA000677B1/en not_active IP Right Cessation
- 1996-05-29 AU AU58824/96A patent/AU709196B2/en not_active Ceased
- 1996-05-29 KR KR1019970708917A patent/KR19990022436A/en not_active Application Discontinuation
- 1996-05-29 JP JP8536616A patent/JPH10506648A/en active Pending
- 1996-05-29 EP EP96920553A patent/EP0828496A1/en not_active Withdrawn
- 1996-05-29 BR BR9609020A patent/BR9609020A/en not_active Application Discontinuation
- 1996-05-29 CA CA002222318A patent/CA2222318A1/en not_active Abandoned
- 1996-05-31 ZA ZA964465A patent/ZA964465B/en unknown
-
1997
- 1997-11-19 IS IS4617A patent/IS4617A/en unknown
- 1997-11-20 BG BG102060A patent/BG63103B1/en unknown
- 1997-12-01 NO NO975527A patent/NO975527L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH10506648A (en) | 1998-06-30 |
NO975527D0 (en) | 1997-12-01 |
BG63103B1 (en) | 2001-04-30 |
CN1192685A (en) | 1998-09-09 |
NZ308935A (en) | 2000-07-28 |
TR199701482T1 (en) | 1998-03-21 |
IL118422A0 (en) | 1996-09-12 |
KR19990022436A (en) | 1999-03-25 |
EE03306B1 (en) | 2000-12-15 |
CA2222318A1 (en) | 1996-12-05 |
AU709196B2 (en) | 1999-08-26 |
EA000677B1 (en) | 2000-02-28 |
AU5882496A (en) | 1996-12-18 |
ZA964465B (en) | 1996-12-11 |
WO1996038156A1 (en) | 1996-12-05 |
BG102060A (en) | 1998-07-31 |
HUP9900659A3 (en) | 2002-12-28 |
EA199700449A1 (en) | 1998-06-25 |
HUP9900659A2 (en) | 2001-04-28 |
BR9609020A (en) | 1999-07-06 |
IS4617A (en) | 1997-11-19 |
EP0828496A1 (en) | 1998-03-18 |
CZ381197A3 (en) | 1998-06-17 |
PL323669A1 (en) | 1998-04-14 |
SK159597A3 (en) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0770615T3 (en) | Process for the preparation of dihalogenazolopyrimidines | |
DE69633333D1 (en) | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC SUBSTANCES | |
DE69604788D1 (en) | HYDROSILYLATION OF UNSATURATED COMPOUNDS | |
NO950760D0 (en) | Process for the preparation of alkyl halosilanes | |
ID19439A (en) | IMPROVEMENT OF ORGANIC COMPOUNDS OR RELATED | |
NO952986D0 (en) | Device for the mutual attachment of two devices | |
IT1276799B1 (en) | FORMULATIONS OF F-SILICONE | |
NO975527L (en) | Use of alendronate to prevent osteoporosis | |
ID17424A (en) | INHIBITION OF METALOPROTEASA MATRIX BY SUBSTITUTED FENETYL COMPOUNDS | |
NO980862D0 (en) | Zwitterinoforms of trovafloxacin | |
DK0721929T3 (en) | Process for the preparation of hydroxyalkoxybenzophenones | |
NO995750D0 (en) | Process for the preparation of a deoxyuridine derivative | |
DK0863874T3 (en) | Process for the preparation of dioxoazabicyclohexanes | |
NO964685L (en) | Isomization of equilin | |
PT761766E (en) | ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE | |
KR970000111U (en) | 3rd phase transfer of the metropolitan equipment system | |
AT204U3 (en) | FOOT SCRAPER | |
KR970010637U (en) | Switchgear of water distributor | |
KR970036510U (en) | Modulator fixing structure of ABS system | |
SE9503245D0 (en) | Preparation of optocomponent plate | |
NO955296D0 (en) | Process for the preparation of concrete construction | |
FI950265A (en) | Wall of element construction | |
NO973476D0 (en) | Process for the preparation of alkyl halosilanes | |
NO945058D0 (en) | Use of phosphonates for the treatment of osteoporosis | |
KR970005433A (en) | How to determine the flange length of the panel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |